title: Radiosurgery for brain metastases at the Royal Adelaide Hospital: are we treating the right patients?
abstract: Although non-randomized data strongly suggest improved outcome from radiosurgery (RS) for brain metastases relative to whole brain radiotherapy (WBRT) alone, selection factors account for much of the observed differences. This retrospective review of the 16 brain metastases patients treated so far with RS at the Royal Adelaide Hospital confirms a median survival of 10.1 months, consistent with recent multi-institutional pooled results and significantly longer than the median survival of 3-6 months typically reported for WBRT alone. The emerging randomized trials comparing surgery, RS and WBRT for brain metastases are reviewed in the context of the Radiation Therapy Oncology Group Recursive Partitioning Analysis prognostic Class concept in order to assess whether we are using this resource intensive technique to treat the 'right' patients. We conclude that it is reasonable to continue our current policy of considering RS primarily for patients of good performance status with solitary brain metastases. We have a flexible approach to adjuvant WBRT which appears to decrease brain relapse, but not improve survival.
authors.affiliation: Department of Radiation Oncology, Adelaide Hospital, South Australia, Australia. droos@mail.rah.sa.gov.au
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Roos
authors.forename: Brian P
authors.initials: BP
authors.lastname: Brophy
authors.forename: Sergei F
authors.initials: SF
authors.lastname: Zavgorodni
authors.forename: Evangelos S
authors.initials: ES
authors.lastname: Katsilis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D016634:Radiosurgery; D012189:Retrospective Studies